US Stock MarketDetailed Quotes

UTMD Utah Medical Products

Watchlist

66.410
-0.370-0.55%

Close Jun 18 16:00 ET

66.700
+0.290+0.44%

Post 19:19 ET

234.32MMarket Cap14.76P/E (TTM)

Utah Medical Products Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-23.70%5.28M

5.36%22.28M

-6.13%5.33M

-8.37%5.12M

1.68%4.91M

37.04%6.92M

-0.26%21.15M

13.90%5.68M

-6.71%5.59M

2.98%4.83M

Net income from continuing operations

-6.12%3.96M

0.98%16.64M

-5.91%4.29M

-8.06%3.94M

2.34%4.2M

19.24%4.21M

11.39%16.47M

10.24%4.56M

1.76%4.28M

19.79%4.1M

Depreciation and amortization

-61.28%683K

-10.08%6.37M

-40.64%1.04M

2.29%1.79M

0.17%1.78M

-2.49%1.76M

-2.77%7.08M

-1.18%1.75M

-4.64%1.75M

-3.69%1.78M

Deferred tax

-18,200.00%-183K

-72.41%-681K

-3,021.43%-409K

-17.07%-144K

10.56%-127K

99.31%-1K

-645.28%-395K

-85.42%14K

30.11%-123K

-161.74%-142K

Change In working capital

-15.56%749K

89.53%-233K

148.46%345K

-45.38%-503K

0.21%-962K

534.80%887K

-121.27%-2.23M

32.89%-712K

-543.59%-346K

-12.75%-964K

-Change in receivables

-111.96%-214K

532.38%2.27M

-74.34%137K

107.67%89K

-62.50%255K

409.52%1.79M

53.54%-525K

262.80%534K

-307.37%-1.16M

252.47%680K

-Change in inventory

125.00%271K

71.53%-670K

188.54%255K

128.19%320K

-33.06%-161K

-33.99%-1.08M

-385.15%-2.35M

11.11%-288K

-380.93%-1.14M

8.33%-121K

-Change in prepaid assets

-448.00%-87K

170.31%45K

144.07%26K

-61.90%16K

-135.48%-22K

122.94%25K

20.99%-64K

-28.26%-59K

300.00%42K

-34.74%62K

-Change in payables and accrued expense

396.18%779K

-362.29%-1.88M

91.88%-73K

-148.64%-928K

34.76%-1.03M

-87.85%157K

3.77%716K

-147.66%-899K

207.74%1.91M

-326.08%-1.59M

Cash from discontinued investing activities

Operating cash flow

-23.70%5.28M

5.36%22.28M

-6.13%5.33M

-8.37%5.12M

1.68%4.91M

37.04%6.92M

-0.26%21.15M

13.90%5.68M

-6.71%5.59M

2.98%4.83M

Investing cash flow

Cash flow from continuing investing activities

111.63%5K

21.88%-639K

-136.84%-90K

42.06%-186K

-44.14%-320K

81.86%-43K

-48.19%-818K

84.98%-38K

-316.88%-321K

-4.72%-222K

Capital expenditure reported

48.84%-22K

21.88%-639K

----

-44.14%-320K

81.86%-43K

---818K

----

-4.72%-222K

Net PPE purchase and sale

--27K

----

--0

----

Cash from discontinued investing activities

Investing cash flow

111.63%5K

21.88%-639K

-136.84%-90K

42.06%-186K

-44.14%-320K

81.86%-43K

-48.19%-818K

84.98%-38K

-316.88%-321K

-4.72%-222K

Financing cash flow

Cash flow from continuing financing activities

-279.69%-3.98M

24.05%-4.17M

-16.41%-1.07M

-0.29%-1.04M

71.56%-1.01M

-5,621.05%-1.05M

49.71%-5.48M

88.60%-920K

-21.41%-1.03M

-242.76%-3.55M

Net common stock issuance

---2.99M

--0

---2.5M

--0

----

Cash dividends paid

-1.78%-1.09M

-35.38%-4.28M

-1.90%-1.07M

-1.81%-1.07M

-0.94%-1.07M

---1.07M

72.41%-3.16M

87.41%-1.05M

-1.25%-1.05M

-2.02%-1.06M

Proceeds from stock option exercised by employees

357.14%96K

-32.76%117K

--0

80.00%36K

1,400.00%60K

10.53%21K

-68.93%174K

-53.05%131K

-89.42%20K

33.33%4K

Cash from discontinued financing activities

Financing cash flow

-279.69%-3.98M

24.05%-4.17M

-16.41%-1.07M

-0.29%-1.04M

71.56%-1.01M

-5,621.05%-1.05M

49.71%-5.48M

88.60%-920K

-21.41%-1.03M

-242.76%-3.55M

Net cash flow

Beginning cash position

23.74%92.87M

23.09%75.05M

26.90%88.21M

27.78%84.62M

22.83%80.91M

23.09%75.05M

18.19%60.97M

8.07%69.51M

11.29%66.22M

17.56%65.87M

Current changes in cash

-77.71%1.3M

17.73%17.48M

-11.67%4.17M

-7.93%3.9M

238.34%3.58M

20.61%5.82M

52.32%14.85M

241.55%4.72M

-16.35%4.24M

-69.25%1.06M

Effect of exchange rate changes

-1,067.57%-358K

144.20%339K

-40.42%488K

67.33%-310K

117.51%124K

-47.89%37K

-111.88%-767K

7,545.45%819K

-281.12%-949K

-2,541.38%-708K

End cash Position

15.94%93.81M

23.74%92.87M

26.90%88.21M

27.78%84.62M

22.83%80.91M

23.09%75.05M

8.07%69.51M

11.29%66.22M

Free cash flow

-23.54%5.25M

6.46%21.64M

-7.09%5.24M

-6.32%4.94M

-0.37%4.59M

42.90%6.87M

-1.56%20.33M

19.18%5.64M

-10.92%5.27M

2.90%4.61M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-23.70%5.28M	5.36%22.28M	-6.13%5.33M	-8.37%5.12M	1.68%4.91M	37.04%6.92M	-0.26%21.15M	13.90%5.68M	-6.71%5.59M	2.98%4.83M
Net income from continuing operations	-6.12%3.96M	0.98%16.64M	-5.91%4.29M	-8.06%3.94M	2.34%4.2M	19.24%4.21M	11.39%16.47M	10.24%4.56M	1.76%4.28M	19.79%4.1M
Depreciation and amortization	-61.28%683K	-10.08%6.37M	-40.64%1.04M	2.29%1.79M	0.17%1.78M	-2.49%1.76M	-2.77%7.08M	-1.18%1.75M	-4.64%1.75M	-3.69%1.78M
Deferred tax	-18,200.00%-183K	-72.41%-681K	-3,021.43%-409K	-17.07%-144K	10.56%-127K	99.31%-1K	-645.28%-395K	-85.42%14K	30.11%-123K	-161.74%-142K
Change In working capital	-15.56%749K	89.53%-233K	148.46%345K	-45.38%-503K	0.21%-962K	534.80%887K	-121.27%-2.23M	32.89%-712K	-543.59%-346K	-12.75%-964K
-Change in receivables	-111.96%-214K	532.38%2.27M	-74.34%137K	107.67%89K	-62.50%255K	409.52%1.79M	53.54%-525K	262.80%534K	-307.37%-1.16M	252.47%680K
-Change in inventory	125.00%271K	71.53%-670K	188.54%255K	128.19%320K	-33.06%-161K	-33.99%-1.08M	-385.15%-2.35M	11.11%-288K	-380.93%-1.14M	8.33%-121K
-Change in prepaid assets	-448.00%-87K	170.31%45K	144.07%26K	-61.90%16K	-135.48%-22K	122.94%25K	20.99%-64K	-28.26%-59K	300.00%42K	-34.74%62K
-Change in payables and accrued expense	396.18%779K	-362.29%-1.88M	91.88%-73K	-148.64%-928K	34.76%-1.03M	-87.85%157K	3.77%716K	-147.66%-899K	207.74%1.91M	-326.08%-1.59M
Cash from discontinued investing activities
Operating cash flow	-23.70%5.28M	5.36%22.28M	-6.13%5.33M	-8.37%5.12M	1.68%4.91M	37.04%6.92M	-0.26%21.15M	13.90%5.68M	-6.71%5.59M	2.98%4.83M
Investing cash flow
Cash flow from continuing investing activities	111.63%5K	21.88%-639K	-136.84%-90K	42.06%-186K	-44.14%-320K	81.86%-43K	-48.19%-818K	84.98%-38K	-316.88%-321K	-4.72%-222K
Capital expenditure reported	48.84%-22K	21.88%-639K	----	----	-44.14%-320K	81.86%-43K	---818K	----	----	-4.72%-222K
Net PPE purchase and sale	--27K	----	----	----	----	--0	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	111.63%5K	21.88%-639K	-136.84%-90K	42.06%-186K	-44.14%-320K	81.86%-43K	-48.19%-818K	84.98%-38K	-316.88%-321K	-4.72%-222K
Financing cash flow
Cash flow from continuing financing activities	-279.69%-3.98M	24.05%-4.17M	-16.41%-1.07M	-0.29%-1.04M	71.56%-1.01M	-5,621.05%-1.05M	49.71%-5.48M	88.60%-920K	-21.41%-1.03M	-242.76%-3.55M
Net common stock issuance	---2.99M	--0	--0	--0	--0	--0	---2.5M	--0	--0	----
Cash dividends paid	-1.78%-1.09M	-35.38%-4.28M	-1.90%-1.07M	-1.81%-1.07M	-0.94%-1.07M	---1.07M	72.41%-3.16M	87.41%-1.05M	-1.25%-1.05M	-2.02%-1.06M
Proceeds from stock option exercised by employees	357.14%96K	-32.76%117K	--0	80.00%36K	1,400.00%60K	10.53%21K	-68.93%174K	-53.05%131K	-89.42%20K	33.33%4K
Cash from discontinued financing activities
Financing cash flow	-279.69%-3.98M	24.05%-4.17M	-16.41%-1.07M	-0.29%-1.04M	71.56%-1.01M	-5,621.05%-1.05M	49.71%-5.48M	88.60%-920K	-21.41%-1.03M	-242.76%-3.55M
Net cash flow
Beginning cash position	23.74%92.87M	23.09%75.05M	26.90%88.21M	27.78%84.62M	22.83%80.91M	23.09%75.05M	18.19%60.97M	8.07%69.51M	11.29%66.22M	17.56%65.87M
Current changes in cash	-77.71%1.3M	17.73%17.48M	-11.67%4.17M	-7.93%3.9M	238.34%3.58M	20.61%5.82M	52.32%14.85M	241.55%4.72M	-16.35%4.24M	-69.25%1.06M
Effect of exchange rate changes	-1,067.57%-358K	144.20%339K	-40.42%488K	67.33%-310K	117.51%124K	-47.89%37K	-111.88%-767K	7,545.45%819K	-281.12%-949K	-2,541.38%-708K
End cash Position	15.94%93.81M	23.74%92.87M	23.74%92.87M	26.90%88.21M	27.78%84.62M	22.83%80.91M	23.09%75.05M	23.09%75.05M	8.07%69.51M	11.29%66.22M
Free cash flow	-23.54%5.25M	6.46%21.64M	-7.09%5.24M	-6.32%4.94M	-0.37%4.59M	42.90%6.87M	-1.56%20.33M	19.18%5.64M	-10.92%5.27M	2.90%4.61M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall